Literature DB >> 15149022

Pathways followed by protein toxins into cells.

Kirsten Sandvig1, Bjørn Spilsberg, Silje U Lauvrak, Maria L Torgersen, Tore-Geir Iversen, Bo van Deurs.   

Abstract

A number of protein toxins have an enzymatically active part, which is able to modify a cytosolic target. Some of these toxins, for instance ricin, Shiga toxin and cholera toxin, which we will focus on in this article, exert their effect on cells by first binding to the cell surface, then they are endocytosed, and subsequently they are transported retrogradely all the way to the ER before translocation of the enzymatically active part to the cytosol. Thus, studies of these toxins can provide information about pathways of intracellular transport. Retrograde transport to the Golgi and the ER seems to be dependent not only on different Rab and SNARE proteins, but also on cytosolic calcium, phosphatidylinositol 3-kinase and cholesterol. Comparison of the three toxins reveals differences indicating the presence of more than one pathway between early endosomes and the Golgi apparatus or, alternatively, that transport of different toxin-receptor complexes present in a certain subcompartment is differentially regulated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149022     DOI: 10.1078/1438-4221-00294

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  46 in total

Review 1.  Targeting of the actin cytoskeleton by insecticidal toxins from Photorhabdus luminescens.

Authors:  Alexander E Lang; Gudula Schmidt; Joel J Sheets; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-12       Impact factor: 3.000

Review 2.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

Review 3.  Revitalizing membrane rafts: new tools and insights.

Authors:  Kai Simons; Mathias J Gerl
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10       Impact factor: 94.444

Review 4.  Trojan horse or proton force: finding the right partner(s) for toxin translocation.

Authors:  C Trujillo; R Ratts; A Tamayo; R Harrison; J R Murphy
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

5.  A conserved motif in transmembrane helix 1 of diphtheria toxin mediates catalytic domain delivery to the cytosol.

Authors:  Ryan Ratts; Carolina Trujillo; Ajit Bharti; Johanna vanderSpek; Robert Harrison; John R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

6.  Gas phase characterization of the noncovalent quaternary structure of cholera toxin and the cholera toxin B subunit pentamer.

Authors:  Jonathan P Williams; Daniel C Smith; Brian N Green; Brian D Marsden; Keith R Jennings; Lynne M Roberts; James H Scrivens
Journal:  Biophys J       Date:  2006-02-03       Impact factor: 4.033

7.  Bordetella pertussis adenylate cyclase toxin translocation across a tethered lipid bilayer.

Authors:  Rémi Veneziano; Claire Rossi; Alexandre Chenal; Jean-Marie Devoisselle; Daniel Ladant; Joel Chopineau
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  Characterization of sinusoidal endothelial cells of the liver and bone marrow using an intravital lectin injection method.

Authors:  Ayako Nakamura-Ishizu; Shunichi Morikawa; Kazuhiko Shimizu; Taichi Ezaki
Journal:  J Mol Histol       Date:  2008-08-28       Impact factor: 2.611

Review 9.  Architecture of the mammalian Golgi.

Authors:  Judith Klumperman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

10.  SDPR induces membrane curvature and functions in the formation of caveolae.

Authors:  Carsten G Hansen; Nicholas A Bright; Gillian Howard; Benjamin J Nichols
Journal:  Nat Cell Biol       Date:  2009-06-14       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.